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Studies with in-vitro-cultured neurons treated with
amyloid- (A) peptides demonstrated neuronal loss by
apoptosis that is due, at least in part, to the perturbation
of intracellular Ca2 homeostasis. In addition, it was
shown that an endoplasmic reticulum (ER)-specific apo-
ptotic pathway mediated by caspase-12, which is acti-
vated upon the perturbation of ER Ca2 homeostasis,
may contribute to A toxicity. To elucidate the involve-
ment of deregulation of ER Ca2 homeostasis in neuro-
nal death induced by A peptides, we have performed a
comparative study using the synthetic peptides A25–35
or A1–40 and thapsigargin, a selective inhibitor of Ca
2
uptake into the ER. Incubation of cortical neurons with
thapsigargin (2.5 M) increased the intracellular Ca2
levels and activated caspase-3, leading to a significant
increase in the number of apoptotic cells. Similarly, upon
incubation of cortical cultures with the A peptides
(A25–35, 25 M; A1–40, 0.5 M), we observed a signif-
icant increase in [Ca2]i, in caspase-3-like activity, and in
number of neurons exhibiting apoptotic morphology. The
role of ER Ca2 release through ryanodine receptors
(RyR) or inositol 1,4,5-trisphosphate receptors (IP3R) in
A neurotoxicity has been also investigated. Dantrolene
and xestospongin C, inhibitors of ER Ca2 release
through RyR or IP3R, were able to prevent the increase in
[Ca2]i and the activation of caspase-3 and to protect
partially against apoptosis induced by treatment with
A25–35 or A1–40. In conclusion, our results demonstrate
that the release of Ca2 from the ER, mediated by both
RyR and IP3R, is involved in A toxicity and can contrib-
ute, together with the activation of other intracellular
neurotoxic mechanisms, to A-induced neuronal death.
This study suggests that A accumulation may have a
key role in the pathogenesis of AD as a result of dereg-
ulation of ER Ca2 homeostasis. © 2004 Wiley-Liss, Inc.
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A defining feature of Alzheimer’s disease (AD), the
most common form of senile dementia, is the accumula-
tion of amyloid- (A; Mattson, 1997), a 39–43-amino-
acid peptide derived from the amyloid precursor protein
(APP; Wisniewski et al., 1997). The importance of A in
the pathogenesis of AD is suggested by several findings.
Notably, mutations in APP or presenilin, two proteins that
are implicated in familiar forms of AD, lead to an increase
in the amyloidogenic forms of A (Selkoe, 1999). In
addition, A1–40 and A1–42 (the principal products re-
sulting from the sequential proteolytic processing of APP
by - and -secretases) and the toxic fragment A25–35
have been shown to be toxic to a wide variety of cells,
including neurons (Yankner, 1996). The mechanism(s) by
which these peptides lead to neuronal loss is not well
understood, so greater understanding is required and is
necessary to future therapeutic intervention. Studies with
in-vitro-cultured neurons treated with amyloidogenic A
peptides demonstrated neuronal loss by an apoptotic path-
way (Loo et al., 1993; Estus et al., 1997). Furthermore,
there is good agreement that A-induced apoptosis is due,
at least in part, to the perturbation of intracellular Ca2
homeostasis (Scorzielo et al., 1996; Huang et al., 2000).
Several studies have suggested that changes in intra-
cellular Ca2 homeostasis play an important role in the
modulation of apoptosis. Many cell death stimuli are
known to alter the concentration of Ca2 in the cytosol
and the storage of Ca2 in the intracellular organelles
(Baffy et al., 1993; Bian et al., 1997). In addition, com-
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pounds that directly affect the intracellular Ca2 ho-
meostasis have been shown to induce apoptosis (Jiang et
al., 1994; Reynolds et al., 1996; Wei et al., 1998). Ca2
release channels in the endoplasmic reticulum (ER), i.e.,
ryanodine receptors (RyR) or inositol 1,4,5-trisphosphate
receptors (IP3R), seem to participate in the signal trans-
duction pathway of apoptosis (Guo et al., 1997; Jayaraman
and Marks, 1997; Pan et al., 2000).
It was recently demonstrated a novel ER-specific
apoptosis pathway in which caspase-12 acts as the initiator
caspase in response to a toxic insult to the ER (Nakagawa
et al., 2000). Caspase-12 is specifically involved in apo-
ptosis that results from stress in the ER and seems to be
activated upon perturbation of ER Ca2 homeostasis (Na-
kagawa et al., 2000; Nakagawa and Yuan, 2000). ER stress
has received growing attention because it is considered a
cause of pathologically relevant apoptosis, and it is impli-
cated particularly in neurodegenerative disorders (Paschen
and Frandsen, 2001). Recent evidence points to the in-
volvement of the ER in AD pathogenesis (Ferri and
Kroemer, 2000; Mattson and Chan, 2001; Mattson et al.,
2001) owing to the fact that it is an important site for
generating A1–40 and A1–42 in neurons (Hartmann et
al., 1998) and that both presenilin proteins are localized
predominantly in this cellular compartment (Walter et al.,
1996).
The goal of the present study was to determine the
role of ER Ca2 release in the neurotoxic effects induced
by the AD-associated A peptides. For that purpose, pri-
mary cultures of rat brain cortical neurons were exposed to
the synthetic peptides A25–35 or A1–40, which have
been shown to be toxic to a wide variety of cells, including
neurons (Mattson, 1997; Pereira et al., 1999; Cardoso et
al., 2002; Casley et al., 2002). In addition, cortical neurons
were treated with thapsigargin, a selective ER Ca2-
ATPase inhibitor that leads to the loss of Ca2 homeostasis
and to apoptotic cell death (Jiang et al., 1994). Agents that
suppress ER Ca2 release through the RyR or the IP3R
were used to investigate the involvement of ER Ca2 release
channels in the deregulation of Ca2 homeostasis and in
the apoptotic death process that occurs upon A exposure.
The results support a mechanistic link among A accu-
mulation, ER dysfunction, and apoptotic neuronal death
in AD.
MATERIALS AND METHODS
Materials
Neurobasal medium and B27 supplement were purchased
from Gibco BRL, Life Technologies (Paisley, United King-
dom). Trypsin, DNase I, trypsin inhibitor type II-S-soybean,
dantrolene, and thapsigargin were obtained from Sigma Chem-
ical Co. (St. Louis, MO). SYTO-13, propidium iodide (PI), and
Indo-1 acetoxymethyl ester (Indo-1/AM) were purchased from
Molecular Probes (Leiden, The Netherlands). The synthetic
A25–35 and A1–40 peptides and the respective reverse se-
quences A35–25 and A40–1 were from Bachem (Bubendorf,
Switzerland). Ionomycin and xestospongin C were purchased
from Calbiochem (Darmstadt, Germany). The colorimetric sub-
strate for caspase-3 [N-acetyl-Asp-Glu-Val-Asp-p-nitroanilide
(DEVD-pNA)] was also from Calbiochem. All the others chem-
icals were obtained from Sigma or from Merck kgaA (Darm-
stadt, Germany).
Primary Cortical Neuronal Cultures and Experimental
Treatments
Primary cultures of cortical cells were prepared from
15–16-day embryos of Wistar rats according to the method
described by Hertz et al. (1989), with some modifications
(Agostinho and Oliveira, 2003). Briefly, the neocortices of
embryos were dissected and placed in Ca2- and Mg2-free
Krebs buffer (in mM): NaCl 120, KCl 4.8, KH2PO4 1.2,
glucose 13, Hepes 10 (pH 7.4), supplemented with 0.3%
(wt/vol) bovine serum albumin (BSA). Minced cortical tis-
sues were washed and incubated in Krebs buffer containing
0.05% (wt/vol) trypsin and 0.004% (wt/vol) DNase I, for
10 min at 37°C. The digestion was stopped with Krebs buffer
containing 0.05% (wt/vol) trypsin inhibitor (type II-S) and
0.004% (wt/vol) DNase I, and the tissue was centrifuged at
140g for 5 min. After the pellet was washed once with Krebs
buffer, the cells were dissolved in fresh Neurobasal medium
supplemented with 2 mM L-glutamine, 2% (vol/vol) B27
supplement, penicillin (100 U/ml), and streptomycin
(100 g/ml) and were dissociated mechanically. Under these
culture conditions, 90% of the cells are neurons as evaluated
using microtubule-associated protein-2 (MAP-2) and glial
fibrillary acidic protein (GFAP) immunoreactivity (data not
shown). Cortical cells were plated on poly-L-lysine (0.1 mg/
ml)-coated plates or coverslips at a density of 0.10  106
cells/cm2 for fluorescence microscopy experiments or at
0.50  106 cells/cm2 for measurement of [Ca2]i and
caspase-3-like activity. The cultures were maintained at 37°C
in a humidified atmosphere of 5% CO2/95% air and were
used for experiments after 5–7 days in vitro. Cortical neurons
were treated with A25–35 or A35–25 (25 M), A1–40 or
A40–1 (0.5 M), or thapsigargin (2.5 M, a concentration
that induces 50% decrease in cell viability at 24 hr) in
serum-free Neurobasal medium supplemented with B27. The
concentrations of A peptides used were chosen based on
previous results demonstrating that 25 M A25–35 and 0.5
M A1–40 induced a maximal toxic effect (50% decrease in
cell viability) on cortical neurons. Before the addition of A
peptides, cells were preincubated for 1 hr with dantrolene
(10 M) or xestospongin C (1 M), concentrations that were
shown to exert maximal protective effects, without being
toxic by themselves (data not shown).
Assessment of Neuronal Injury
After treatment of cortical cells with thapsigargin or with
A peptides, neuronal injury was assessed by analysis of the
nuclear morphology by fluorescence microscopy of live cells
using the stains PI, which fluoresces red and enters the cells only
when membrane integrity is lost, and SYTO-13, which fluo-
resces green and enters the cells with intact cytoplasmic mem-
brane (Rego et al., 2001). Cortical cells cultured on glass cov-
erslips were treated with thapsigargin or with A peptides in the
absence or in the presence of dantrolene or xestospongin C.
After washing, cells were incubated in sodium medium (in
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mM): NaCl 132, KCl 4, NaH2PO4 1.2, MgCl2 1.4, glucose 6,
HEPES-Na 10, and CaCl2 1, pH 7.4, containing 3.8 M
SYTO-13 and 2.5 g/ml of PI for 3 min at 37°C. Viable,
necrotic, or apoptotic neurons were visualized by nuclear mor-
phology criteria. Viable neurons display a normal nuclear size
and green fluorescence. Necrotic neurons manifest red fluores-
cence without chromatin condensation. Scored apoptotic neu-
rons include neurons that display pyknotic nuclei with con-
densed or fragmented chromatin and fluoresce green and
secondary necrotic neurons that display condensed or frag-
mented chromatin and fluoresce red. Cells were examined and
scored with a Nikon Diaphot TMP microscope. All experi-
ments were performed in duplicate, and at minimum 300 cells
were scored for each coverslip. The number of viable, necrotic,
and apoptotic cells was expressed as the percentage of the total
number of cells in the microscope field.
Measurement of Intracellular Ca2 Concentration
Control or treated cortical cells cultured on glass cover-
slips were incubated with 3 M Indo-1/AM in a sodium
medium containing (in mM): NaCl 132, KCl 4, CaCl2 1,
MgCl2 1.4, glucose 6, HEPES-Na 10, pH 7.4, for 45 min at
37°C. The cells were further incubated in sodium medium for
15 min at 37°C to ensure a complete hydrolysis of the ace-
toxymethyl ester of Indo-1. After being washed, cells were
mounted in a special holder, and the Indo-1 fluorescence was
measured with excitation of 335 nm and 410 nm emission. The
free intracellular Ca2 concentration ([Ca2]i) was calculated as
previously described (Bandeira-Duarte et al., 1990).
Caspase-3-Like Activity Assay
Untreated or treated cortical cells were lysed with a buffer
containing (in mM): HEPES-Na 25, MgCl2 2, EDTA 1, EGTA
1, supplemented with 100 M phenylmethylsulfonyl fluoride
(PMSF), 2 mM dithiothreitol (DTT), and a protease inhibitor
cocktail (containing 1 g/ml leupeptin, pepstatin A, chymosta-
tin, and aprotinin). The cellular suspension was rapidly frozen/
defrosted three times and then centrifuged for 10 min at
20,200g. The supernatant was collected and assayed for protein
content by using the Bio-Rad protein dye assay reagent. To
measure caspase-3-like activity, aliquots of cell extracts contain-
ing 25 g of protein were incubated for 2 hr at 37°C, in a
reaction buffer containing 25 mM HEPES-Na, 10 mM DTT,
10% (wt/vol) sucrose, and 0.1% (wt/vol) CHAPS (pH 7.4),
with 100 M Ac-DEVD-pNA, a chromogenic substrate for
caspase-3 (Cregan et al., 1999). Caspase-3-like activity was
determined by measuring substrate cleavage at 405 nm with a
microplater reader. Results were expressed as the increase above
control absorbance at 405 nm.
Statistical Analysis
Results are expressed as means  SEM of the number of
experiments indicated in the figure legends. Statistical signifi-
cance was analyzed by analysis of variance (ANOVA), followed
by Dunnett’s post hoc tests for multiple comparisons or by the
unpaired two-tailed Student’s t-test. P  .05 was considered
statistically significant.
RESULTS
Intracellular Calcium Levels Are Increased in
Cortical Neurons Treated With A25–35, A1–40,
and Thapsigargin; Dantrolene and Xestospongin C
Prevent A-Induced [Ca2]i Rise
To analyze the involvement of ER Ca2 release in
the toxic effects of A25–35 or A1–40 on cortical neuronal
cultures, the intracellular Ca2 levels were determined in
the absence or in the presence of dantrolene or xestospon-
gin C, which inhibit the release of Ca2 through the ER
RyR or IP3R, respectively. In addition, cytosolic Ca
2
concentration was determined in neurons exposed to
thapsigargin, a known inhibitor of the ER Ca2-ATPase
that deregulates ER Ca2 homeostasis.
Treatment of cells with 25 M A25–35 increased
the intracellular Ca2 levels, as shown in Figure 1. After
24 hr, the [Ca2]i increased from 122.60  9.78 nM in
control to 201.90  20.65 nM in A25–35-treated cells.
When cells were preincubated for 1 hr with dantrolene
(10 M) or xestospongin C (1 M) before A25–35 ad-
dition, the intracellular Ca2 levels decreased significantly
and were similar to those determined for controls (Fig. 1).
The [Ca2]i measured after incubation with A25–35 dur-
ing 24 hr, in the presence of dantrolene, was 152.30 
3.11 nM and the [Ca2]i measured after A25–35 exposure
during 24 hr, in the presence of xestospongin C, was
Fig. 1. Effect of A25–35, A1–40, and thapsigargin on basal intracel-
lular Ca2 levels in cortical neurons. Cells cultured on coverslips were
treated, for 24 hr, with A25–35 (25 M), A1–40 (0.5 M), in the
absence or in the presence of dantrolene or xestospongin C, or with
thapsigargin (2.5 M). The fluorescence of Indo-1-loaded cells was
measured, and the [Ca2]i was calculated as described in Materials and
Methods. The results are the means  SEM of values corresponding to
at least three experiments, each value being the mean of duplicate
assays. ***P  .001 with respect to control values. #P  .05, ##P 
.01 with respect to A addition.
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125.60  9.64 nM. Cells treated with A1–40 (0.5 M)
also showed an increament in intracellular Ca2 levels in
comparison with controls (Fig. 1). After treatment for
24 hr with A1–40, [Ca
2]i increased 2.7-fold above con-
trol values (Ca2 levels increased from 122.60  9.78 nM
in controls to 336.10  9.37 nM in cells treated with
A1–40). When cells were pretreated with dantrolene (10
M) or xestospongin C (1 M) before A1–40 addition,
intracellular Ca2 levels decreased significantly (Fig. 1).
Intracellular Ca2 levels decreased from 336.10 
9.37 nM to 219.50  36.90 nM vs. 240.80  12.60 nM
in cells treated with A1–40 in the absence or in the
presence of dantrolene vs. xestospongin C, respectively.
Incubation of cortical neurons with dantrolene or xesto-
spongin C alone during 24 hr did not affect the [Ca2]i
compared with control. Unlike A25–35 and A1–40, the
reverse peptides A35–25 (25 M) and A40–1 (0.5 M)
were not able to increase intracellular free Ca2 levels.
When cells were treated with 2.5 M thapsigargin,
an increase in intracellular Ca2 levels was also observed
(Fig. 1). After incubation of cortical neurons with thapsi-
gargin during 24 hr, the [Ca2]i increased 2.2-fold above
control values (Ca2 levels increased from 122.60 
9.78 nM in controls to 269.30 8.69 nM in thapsigargin-
treated cells at 24 hr).
Caspase-3 Activation Occurs After A25–35 or
A1–40 and Thapsigargin Treatment; Dantrolene
and Xestospongin C Protect From A-Induced
Caspase-3 Activation
Cells treated with A25–35 (25 M) for 24 or 48 hr
showed a significant increase in caspase-3-like activity
(Fig. 2), this increase being higher after 24 hr than after
48 hr of treatment. A 3.58-fold increase above control in
the activity of caspase-3 was determined in cells exposed to
A25–35 during 24 hr, whereas an increment of 2.23-fold
was measured in cells treated with this peptide during
48 hr. When cells were treated with A1–40 (0.5 M), a
significant increase in caspase-3 activation was observed at
48 hr of treatment, but no caspase-3 activation was dem-
onstrated after 24 hr of incubation (Fig. 2). A1–40 (0.5
M) induced a 1.67-fold increase above control values.
Caspase-3-like activity was not significantly affected by
treatment with the reverse peptides (A35–25, 25 M, and
A40–1, 0.5 M).
Cells treated with thapsigargin also demonstrated
caspase-3 activation (Fig. 2). An activation of 7.20-fold
was determined for caspase-3 upon 24 hr incubation with
2.5 M thapsigargin. No significant differences were de-
tected in caspase-3 activity between 24 and 48 hr incuba-
tion in the presence of thapsigargin.
Because caspase-3 activation is higher after incuba-
tion for 24 hr than for 48 hr in the presence of A25–25
(25 M) and because caspase-3 is only activated upon
exposure of A1–40 (0.5 M) for 48 hr, the protective
effect of dantrolene and xestospongin C against A-
induced caspase-3 activation was analyzed under these
experimental conditions. As shown in Figure 3A, prein-
cubation of cortical cells with dantrolene or xestospongin
C before A25–35 (25 M) addition significantly reduced
caspase-3 activation induced by this peptide (Ac-DEVD-
pNA cleavage decreased from 3.58  0.72 to 1.53  0.20
vs. 1.48 0.04 in cells treated with A25–35 in the absence
or in the presence of dantrolene vs. xestospongin C,
respectively). Cells pretreated with dantrolene or xesto-
spongin C before A1–40 addition showed a significant
decrease in caspase-3 like activity (Ac-DEVD-pNA cleav-
age decreased from 1.67 0.33 to 1.01 0.05 vs. 0.86
0.14 in cells treated with A1–40 in the absence or in the
presence of dantrolene vs. xestospongin C, respectively;
Fig. 3B).
A25–35, A1–40, and Thapsigargin Reduce Cell
Viability and Induce Apoptosis; Dantrolene and
Xestospongin C Protect From A Toxicity
In cortical neurons, the number of viable, necrotic,
and apoptotic cells upon exposure to A peptides or
thapsigargin was analyzed by fluorescence microscopy af-
ter SYTO-13/PI labeling. Exposure of cortical neurons to
A25–35 (25 M) revealed a reduction in the number of
viable cells after 48 hr of incubation (Fig. 4A). Dantrolene
(10 M) and xestospongin C (1 M) protected cortical
neurons against A25–35-induced toxicity (the number of
viable cells was 46.89%  1.94%, 71.3%  2.22%, and
81.78%  3.01% in cells treated with A25–35 alone, with
A25–35 plus dantrolene, or with A25–35 plus xestospon-
gin C, respectively). Incubation of cortical neurons with
A25–35 peptide during 48 hr increased significantly the
Fig. 2. Caspase-3 activation in cortical neurons induced by A25–35,
A1–40, or thapsigargin. After incubation for 24 or 48 hr with 25 M
A25–35, 0.5 M A1–40, or 2.5 M thapsigargin, the cultured cortical
cells were lysed, and the protein was extracted. Caspase-3-like activity
was determined by measuring the cleavage of the chromogenic sub-
strate Ac-DEVD-pNA at 405 nm, as described in Materials and Meth-
ods. The results, expressed as the increase above control values, are the
means  SEM of values corresponding to at least to three experiments,
each value being the mean of duplicate assays. *P  .05, ***P  .001
with respect to control values.
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number of necrotic cells, the increase being prevented by
dantrolene or xestospongin C (35.24%  2.39%, 15.68%
 3.01%, and 9.26%  2.76% in cells treated with
A25–35 alone, with A25–35 plus dantrolene, or with
A25–35 plus xestospongin C, respectively). Furthermore,
in the presence of A25–35 a higher number of neurons
exhibiting apoptotic morphology was observed (from
2.76%  0.47% in controls to 25.68%  1.48% in
A25–35-treated cells; Fig. 4A). Dantrolene was shown to
prevent significantly, although partially, the A25–35-
induced increase in the number of apoptotic cells (8.21%
 1.15% or 25.68%  1.48% apoptotic cells after treat-
ment with A25–35 in the presence or in the absence of
dantrolene). Similarly, xestospongin C prevented the in-
crease in the number of apoptotic cells induced by A25–35
(8.51%  0.91% or 25.68%  1.48% apoptotic cells after
treatment with A25–35 in the presence or in the absence
of xestospongin C). Treatment of cortical cells with
A35–25 (25 M) for 48 hr did not affect the number of
viable, necrotic, or apoptotic cells in comparison with the
control situation (Fig. 4A).
Similar analysis was performed for the peptide
A1–40 (0.5 M). As observed for the A25–35 peptide,
the SYTO-13/PI labeling also revealed a reduction in cell
viability in cortical neurons treated with A1–40 (0.5 M)
for 48 hr and the protective effect of dantrolene and
xestospongin C (the number of viable cells was 50.95% 
2.43%, 77.74%  1.98%, or 73.33%  3.00% in cells
treated with A1–40 alone, with A1–40 plus dantrolene,
or with A1–40 plus xestospongin C, respectively; Fig.
4B). Furthermore, the number of necrotic cells after
A1–40 exposure (28.09%  1.46%) is higher compared
with control (13.95%  1.24%). The incubation with
dantrolene and A1–40 or with xestospongin C and
A1–40 reduced the number of necrotic cells, exerting its
protective effect over cortical neurons (10.05%  1.45%
or 11.25%  0.65%, respectively). Likewise, upon treat-
ment of cortical neurons with A1–40, the number of
apoptotic cells increased above control (2.76%  0.48%
and 20.96%  1.80% in control cells and A1–40-treated
cells, respectively). Once again, both dantrolene and xes-
tospongin C show a protective effect evident in the re-
duced number of apoptotic cells (5.68%  0.76% or
5.71% 0.95% with A1–40 in the presence of dantrolene
or xestospongin C, respectively). Treatment of cortical
cells with the reverse peptide, A40–1 (0.5 M), for 48 hr
did not affect the number of viable, necrotic, or apoptotic
cells (Fig. 4B). Incubation of cortical neurons with dan-
trolene or xestospongin C alone did not affect the SYTO-
13/PI fluorescence in comparison with controls.
Finally, data obtained also demonstrated a decrease in
the number of viable cells and an increase in the number of
apoptotic cells after incubation with thapsigargin (Fig. 4C).
The number of viable cells decreased from 79.36%  2.26%
in controls to 55.32%  4.47% or 35.05%  2.54% in
thapsigargin-treated cells and the number of apoptotic cells
increased from 2.76%  0.47% in controls to 24.25% 
2.67% or 54.40% 2.54% upon treatment with thapsigargin
during 24 or 48 hr, respectively. The number of necrotic cells
was not significantly affected upon thapsigargin treatment.
DISCUSSION
Our results with primary cultures of rat brain cortical
neurons showed that incubation with the A25–35 or
A1–40 peptides significantly increases the [Ca
2]i, acti-
vates caspase-3, and leads to apoptotic cell death. On the
Fig. 3. Effect of dantrolene and xestospongin C on the increase in caspase-
3-like activity induced by A25–35 (A) or A1–40 (B). After incubation for
24 hr with the peptide A25–35 (25 M) and incubation for 48 hr with the
peptide A1–40 (0.5 M), the cultured cortical cells were lysed, and the
protein was extracted. Caspase-3-like activity was determined by measur-
ing Ac-DEVD-pNA cleavage at 405 nm, as described in Materials and
Methods. The results, expressed as the increase above control values, are
the means SEM of values corresponding to at least to three experiments,
each value being the mean of duplicate assays. ***P  .001 with respect
to control values. ###P  .001 with respect to A addition.
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other hand, the reversed peptides, A35–25 or A40–1,
were not able to induce neuronal injury. The inhibitors of
the ER Ca2 release through the RyR and IP3R, dan-
trolene and xestospongin C, respectively, prevented the
[Ca2]i rise, the activation of caspase-3, or the increase in
number of cells exhibiting apoptotic morphology trig-
gered by the A peptides. Therefore, the present study
demonstrates that Ca2 release through the ER RyR or
IP3R is induced by the A peptides and is involved in
A-induced apoptotic death. The comparative study per-
formed with thapsigargin, a selective ER Ca2-ATPase
inhibitor, which was shown to lead to the loss of Ca2
homeostasis, to caspase-3 activation, and to apoptotic cell
death, further supports this hypothesis.
Several studies have suggested that changes in intra-
cellular Ca2 homeostasis play an important role in the
modulation of apoptosis. Compounds that directly affect
the intracellular Ca2 homeostasis have been shown to
induce apoptosis (Jiang et al., 1994; Reynolds et al., 1996).
The antiapoptotic protein Bcl-2 protects against
thapsigargin-induced increases of Ca2 and apoptosis and
was shown to suppress Ca2 release from ER (Guo et al.,
1997; Wei et al., 1998). Recently, degradation of
caspase-3, cleavage of poly(ADP-ribose) polymerase,
DNA fragmentation, and cell death were observed in
human neuroblastoma SH-SY5Y cells treated with thap-
sigargin (Kitamura et al., 2003). Previous studies with
in-vitro-cultured neurons treated with A peptides dem-
onstrated neuronal loss by apoptosis (Loo et al., 1993;
Estus et al., 1997) that was due at least in part to the
perturbation of intracellular Ca2 homeostasis (Scorzielo
et al., 1996; Huang et al., 2000). However, the routes of
Ca2 homeostasis deregulation in A-treated cells remain
controversial. Ca2 influx through voltage-sensitive Ca2
channels has been reported to be involved in the neuro-
toxic effects of A25–35 (Guo et al., 1996; Ekinci et al.,
2000). Others have hypothesized that the ability of A
peptides to form amyloid channels, and the subsequent
disruption of Ca2 homeostasis, could be the molecular
basis of the neurotoxicity of these peptides (Kawahara and
Kuroda, 2000). Guo et al. (1996, 1997) have demonstrated
that Ca2 release from RyR is involved in A25–35 tox-
icity in PC12 cells. In the present study, with cortical
neurons in culture, we have shown that, in addition to
Ca2 release through RyR, IP3R also contributes to
A25–35- and also A1–40-induced cell death, insofar as
the increase in [Ca2]i and the induction of apoptotic cell
death were significantly prevented by dantrolene and also
by xestospongin C, a specific inhibitor of IP3R-mediated
Ca2 release. IP3-mediated Ca
2 release from the ER was
previously demonstrated to trigger apoptosis in response to
diverse signals (Distelhorst and Roderick, 2003). Many
cell death stimuli are known to alter the concentration of
Ca2 in the cytosol and the storage of Ca2 in the
intracellular organelles (Baffy et al., 1993; Bian et al.,
1997). Lam et al. (1993) showed that glucocorticoids
induce release of calcium from ER, which is correlated
with subsequent DNA fragmentation and apoptosis.
Moreover, Ca2 release channels in the ER, i.e., IP3R
and RyR, seem to participate in the signal transduction
pathway of apoptosis (Guo et al., 1997; Jayaraman and
Marks, 1997; Pan et al., 2000). Dubrez et al. (2001) have
Fig. 4. DNA fragmentation induced by A25–35, A1–40, or thapsigargin.
Cultured cortical neurons were treated, for 48 hr, with A25–35 (25 M;
A) or A1–40 (0.5 M; B), in the absence or in the presence of dantrolene
or xestospongin C, or with thapsigargin (2.5 M) for 24 and 48 hr (C).
The cells were then incubated with SYTO-13 and PI to visualize nuclei
morphology and were scored with a fluorescence microscope. The results,
expressed as the percentage of the total number of cells, are the means 
SEM of values corresponding to at least to three experiments, each value
being the mean of duplicate assays. *P .05, ***P .001 with respect to
control values. ###P  .001 with respect to A addition.
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shown that caffeine, a well-known inducer of Ca2 release
through ryanodine-sensitive Ca2 channels expressed in
ER, induces translocation of the proapoptotic protein Bax
to the mitochondria, leading to caspase-3 activation and
apoptotic cell death. Recent studies indicate that IP3R-
mediated Ca2 spikes trigger opening of the mitochon-
drial permeability transition pore and, in turn, the release
of cytochrome c (Szalai et al., 1999; Brustovetsky et al.,
2002). The effect of added extracellular A peptides on
intracellular Ca2 stores located at the ER could involve
a direct action of A on surface membrane constituents,
which could modulate the activity of intracellular constit-
uents. It was previously demonstrated that A toxicity
involves the early induction of membrane lipid peroxida-
tion, which liberates 4-hydroxynonenal that binds to ion
channels at the ER and thereby alters their activities,
leading to the perturbation of ER Ca2 homeostasis
(Mattson, 1998). Furthermore, A peptides could be in-
ternalized and act directly on the ER Ca2 channel,
increasing its Ca2 sensitivity, as occurs with caffeine
(Zhao et al., 2001), or could form a pore permeable to
Ca2 in the ER membrane.
ER Ca2 release has been shown to have immediate
effects on mitochondrial function, leading to rapid Ca2
accumulation in mitochondria, which promotes cyto-
chrome c release and activation of downstream caspase
pathways in cells exposed to proapoptotic agents (Nutt et
al., 2002). The A25–35- or A1–40-induced release of
Ca2 from ER might stimulate mitochondrial Ca2 up-
take, leading to cytochrome c release and activation of a
caspase-dependent apoptotic cascade. In our laboratory, it
was recently demonstrated that incubation of cortical neu-
rons with A25–35 (25 M) increases mitochondrial cyto-
chrome c release and activates caspase-3 (Agostinho and
Oliveira, 2003). Moreover, mitochondrial dysfunction
was previously demonstrated upon A25–35 or A1–40
treatment (Pereira et al., 1998). Taken together, these
observations suggest that ER stress induced by the disrup-
tion of Ca2 homeostasis in neuronal cells exposed to A
peptides may be associated with mitochondrial dysfunc-
tion. The disruption of Ca2 homeostasis mediated
through Ca2 release by ER IP3R and RyR may be
intermediate between ER stress and mitochondrial dys-
function. In human neuroblastoma cells, both ER- and
mitochondrial-dependent pathways were shown to be in-
volved in thapsigargin-induced apoptosis (Kitamura et al.,
2003).
One of the mechanisms involved in the activation of
apoptotic cell death upon A25–35- and A1–40-induced
Ca2 release from ER could be related to calcineurin
activation. It was recently demonstrated in our laboratory
that this Ca2/calmodulin-dependent phosphatase is in-
volved in A25–35 toxicity in cortical neurons (Agostinho
and Oliveira, 2003). Calcineurin has previously been pro-
posed as a link between Ca2 deregulation and neuronal
cell death (Wang et al., 1999; Foster et al., 2001). Jayara-
man and Marks (2000) have shown that calcineurin is
downstream of the IP3R in the apoptotic pathway, sup-
porting the involvement of ER Ca2 homeostasis dereg-
ulation in calcineurin-mediated apoptosis. When acti-
vated, calcineurin dephosphorylates the proapoptotic
BAD protein, allowing its translocation to the mitochon-
dria, where it binds to antiapoptotic Bcl-2 family members
and induces cytochrome c release (Springer et al., 2000).
In the cytosol, cytochrome c binds Apaf-1 and dATP to
form a complex that activates caspase-9, which can acti-
vate the executioner caspase-3 (Desagher and Martinou,
2000).
Several studies have shown that caspase-3 activation
is an initial event in neurodegeneration induced by
A25–35 (Mattson et al., 1998; Harada and Sugimoto,
1999; Xiao et al., 2002). Under our experimental condi-
tions, caspase-3 activity increased upon treatment with
A25–35 or A1–40, this increase being prevented by the
ER Ca2 release inhibitors dantrolene and xestospongin
C, which suggests that perturbation of ER Ca2 ho-
meostasis mediated by Ca2 release from RyR and IP3R
is involved in the activation of caspase-3. Furthermore,
thapsigargin significantly increased caspase-3 activity, sup-
porting the activation of this caspase executioner of apo-
ptosis under conditions of perturbed ER Ca2 homeosta-
sis. Increased Ca2 release from ER has been previously
associated with caspase-3 activation (Kim et al., 2002). In
addition, activation of caspase-3 has been shown to be
completely suppressed in cells overexpressing Bcl-2 tar-
geted specifically to the ER (Ha¨cki et al., 2000).
In conclusion, our results show that A25–35 and
A1–40 induce Ca
2 homeostasis deregulation, caspases
activation, and apoptotic neuronal death. Dantrolene and
xestospongin C, inhibitors of the ER Ca2-release chan-
nels RyR and IP3R, respectively, prevented the A25–35-
or A1–40-induced rise in [Ca
2]i, caspases activation, and
apoptotic cell death, indicating that Ca2 release through
the ER RyR and IP3R is involved in the neurotoxicity
induced by these peptides. This hypothesis is further sup-
ported by the data obtained with thapsigargin, an inhibitor
of the ER Ca2-ATPase. Therefore, ER stress resulting
from deregulation of ER Ca2 homeostasis seems to play
a crucial role in neurodegeneration triggered by the AD-
associated A peptide. However, because of the partial
protective effect of dantrolene and xestospongin C against
A-induced neuronal death, it cannot be ruled out the
hypothesis that other intracellular neurotoxic mechanisms
could be triggered by the A peptides and contribute to
apoptotic death, in a manner independent of or synergistic
with Ca2-sensitive ER stress. Given the role of perturbed
ER function in AD (Mattson and Chan, 2001; Mattson et
al., 2001), the regulation of ER Ca2 homeostasis can be
a target for the treatment of this neurodegenerative disor-
der.
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